Cargando…
Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue
BACKGROUND: The purpose of the work reported here is to test reliable molecular profiles using routinely processed formalin-fixed paraffin-embedded (FFPE) tissues from participants of the clinical trial BIG 1-98 with a median follow-up of 60 months. METHODS: RNA from fresh frozen (FF) and FFPE tumor...
Autores principales: | Antonov, Janine, Popovici, Vlad, Delorenzi, Mauro, Wirapati, Pratyaksha, Baltzer, Anna, Oberli, Andrea, Thürlimann, Beat, Giobbie-Hurder, Anita, Viale, Giuseppe, Altermatt, Hans Jörg, Aebi, Stefan, Jaggi, Rolf |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829498/ https://www.ncbi.nlm.nih.gov/pubmed/20144231 http://dx.doi.org/10.1186/1471-2407-10-37 |
Ejemplares similares
-
Expression profiling with RNA from formalin-fixed, paraffin-embedded material
por: Oberli, Andrea, et al.
Publicado: (2008) -
Selecting control genes for RT-QPCR using public microarray data
por: Popovici, Vlad, et al.
Publicado: (2009) -
Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
por: Regan, Meredith M, et al.
Publicado: (2011) -
Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases
por: Bustamante Eduardo, Mariana, et al.
Publicado: (2019) -
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
por: Desmedt, Christine, et al.
Publicado: (2009)